Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration

D. Husereau,M. Drummond,S. Petrou,D. Greenberg,J. Mauskopf,F. Augustovski,A. H. Briggs,D. Moher,E. Loder and C. Carswell. Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration. Pharmacoeconomics. 2015;33(5):10.1007/s40273-015-0277-8.